Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 3
1946 2
1948 3
1951 1
1953 1
1958 1
1959 1
1964 1
1970 2
1974 1
1978 1
1979 1
1980 2
1982 4
1984 1
1985 2
1986 1
1987 2
1988 1
1989 2
1990 2
1991 4
1993 1
1994 3
1995 4
1996 5
1997 9
1998 7
1999 7
2000 3
2001 3
2002 5
2003 6
2004 5
2005 2
2006 3
2007 5
2008 6
2009 5
2010 9
2011 9
2012 6
2013 4
2014 6
2015 5
2016 3
2017 6
2018 6
2019 6
2020 12
2021 3
2022 8
2023 9
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

205 results

Results by year

Filters applied: . Clear all
Page 1
Current recommendations and recent progress in endometrial cancer.
Brooks RA, Fleming GF, Lastra RR, Lee NK, Moroney JW, Son CH, Tatebe K, Veneris JL. Brooks RA, et al. Among authors: moroney jw. CA Cancer J Clin. 2019 Jul;69(4):258-279. doi: 10.3322/caac.21561. Epub 2019 May 10. CA Cancer J Clin. 2019. PMID: 31074865 Free article. Review.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Moore KN, Angelergues A, Konecny GE, García Y, Banerjee S, Lorusso D, Lee JY, Moroney JW, Colombo N, Roszak A, Tromp J, Myers T, Lee JW, Beiner M, Cosgrove CM, Cibula D, Martin LP, Sabatier R, Buscema J, Estévez-García P, Coffman L, Nicum S, Duska LR, Pignata S, Gálvez F, Wang Y, Method M, Berkenblit A, Bello Roufai D, Van Gorp T; Gynecologic Oncology Group Partners and the European Network of Gynaecological Oncological Trial Groups. Moore KN, et al. Among authors: moroney jw. N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169. N Engl J Med. 2023. PMID: 38055253 Clinical Trial.
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.
Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer.
Chen S, Xie P, Cowan M, Huang H, Cardenas H, Keathley R, Tanner EJ, Fleming GF, Moroney JW, Pant A, Akasha AM, Davuluri RV, Kocherginsky M, Zhang B, Matei D. Chen S, et al. Among authors: moroney jw. J Clin Invest. 2022 Jul 15;132(14):e158800. doi: 10.1172/JCI158800. J Clin Invest. 2022. PMID: 35671108 Free PMC article. Clinical Trial.
The Chlamydomonas genome reveals the evolution of key animal and plant functions.
Merchant SS, Prochnik SE, Vallon O, Harris EH, Karpowicz SJ, Witman GB, Terry A, Salamov A, Fritz-Laylin LK, Maréchal-Drouard L, Marshall WF, Qu LH, Nelson DR, Sanderfoot AA, Spalding MH, Kapitonov VV, Ren Q, Ferris P, Lindquist E, Shapiro H, Lucas SM, Grimwood J, Schmutz J, Cardol P, Cerutti H, Chanfreau G, Chen CL, Cognat V, Croft MT, Dent R, Dutcher S, Fernández E, Fukuzawa H, González-Ballester D, González-Halphen D, Hallmann A, Hanikenne M, Hippler M, Inwood W, Jabbari K, Kalanon M, Kuras R, Lefebvre PA, Lemaire SD, Lobanov AV, Lohr M, Manuell A, Meier I, Mets L, Mittag M, Mittelmeier T, Moroney JV, Moseley J, Napoli C, Nedelcu AM, Niyogi K, Novoselov SV, Paulsen IT, Pazour G, Purton S, Ral JP, Riaño-Pachón DM, Riekhof W, Rymarquis L, Schroda M, Stern D, Umen J, Willows R, Wilson N, Zimmer SL, Allmer J, Balk J, Bisova K, Chen CJ, Elias M, Gendler K, Hauser C, Lamb MR, Ledford H, Long JC, Minagawa J, Page MD, Pan J, Pootakham W, Roje S, Rose A, Stahlberg E, Terauchi AM, Yang P, Ball S, Bowler C, Dieckmann CL, Gladyshev VN, Green P, Jorgensen R, Mayfield S, Mueller-Roeber B, Rajamani S, Sayre RT, Brokstein P, Dubchak I, Goodstein D, Hornick L, Huang YW, Jhaveri J, Luo Y,… See abstract for full author list ➔ Merchant SS, et al. Among authors: moroney jv. Science. 2007 Oct 12;318(5848):245-50. doi: 10.1126/science.1143609. Science. 2007. PMID: 17932292 Free PMC article.
Closing the circle.
Machingura MC, Moroney JV. Machingura MC, et al. Among authors: moroney jv. Elife. 2018 Nov 14;7:e42507. doi: 10.7554/eLife.42507. Elife. 2018. PMID: 30426925 Free PMC article.
Epigenetics of the antibody and autoantibody response.
Moroney JB, Chupp DP, Xu Z, Zan H, Casali P. Moroney JB, et al. Curr Opin Immunol. 2020 Dec;67:75-86. doi: 10.1016/j.coi.2020.09.004. Epub 2020 Nov 8. Curr Opin Immunol. 2020. PMID: 33176228 Free PMC article. Review.
Gall-stone ileus.
MORONEY J. MORONEY J. Lancet. 1945 Nov 10;2(6378):613. doi: 10.1016/s0140-6736(45)91639-4. Lancet. 1945. PMID: 21003838 No abstract available.
Immunotherapy toxicities: An SGO clinical practice statement.
O'Cearbhaill RE, Clark L, Eskander RN, Gaillard S, Moroney J, Pereira E, Pothuri B. O'Cearbhaill RE, et al. Among authors: moroney j. Gynecol Oncol. 2022 Jul;166(1):25-35. doi: 10.1016/j.ygyno.2022.05.003. Epub 2022 May 18. Gynecol Oncol. 2022. PMID: 35597686 Free PMC article. No abstract available.
205 results